Overview
Description
Nirvana Life Sciences Inc. is a biotech company focused on developing innovative solutions in the pharmaceutical landscape. Primarily engaged in researching and developing medically beneficial products derived from psychedelic compounds, the company aims to address various neurological and psychological disorders. Nirvana Life Sciences concentrates efforts in areas including chronic pain management, mental health conditions, and addiction treatment, offering a potential paradigm shift in therapeutics. Operating in the burgeoning psychedelic space, the company aligns with ongoing trends in mental health awareness and the de-stigmatization of alternative treatment modalities. By advancing its product pipeline, Nirvana Life Sciences contributes to the broader understanding and acceptance of psychedelics in medicine, positioning itself at the forefront of this evolving industry. The company's commitment to rigorous research and scientific validation underscores its role in potentially transforming traditional therapeutic practices.
About
CEO
Mr. Bruce Clark
Employees
0
Address
650 West Georgia Street
Suite 2100
Vancouver, V6B 4N8, BC
Canada
Suite 2100
Vancouver, V6B 4N8, BC
Canada
Phone
604-401-8100
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
Canada
MIC code
XCNQ